Input CIK:

Show Other Options & Instructions

Owned(%):
Shares Outstanding(‱):
Transaction Code:

Instructions

Month Back: Display transaction record of previous n months.

Owned(%): Transaction shares relative to shares owned.

Shares Outstanding(‱): Transaction shares relative to shares outstanding.

Check Insider Trading (Reporter) for more details.

SCHENKEIN DAVID P 1578200 Data last updated 2024-05-14 07:02:16 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.

3M 6M 1Y 2Y MAX

Non-derivative Transactions     CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-06-05 2023-06-01 4 Schenkein David P DIRECTOR holding 26232.0 0 1.92 0.0 See Footnote F4 Common Stock DENALI THERAPEUTICS INC.

code_

NA 		136.89 (DNLI)
2023-06-05 2023-06-01 4 Schenkein David P DIRECTOR holding 31232.0 0 2.28 0.0 See Footnote F3 Common Stock DENALI THERAPEUTICS INC.

code_

NA 		136.89 (DNLI)
2023-06-05 2023-06-01 2023-06-01 4 Schenkein David P DIRECTOR acq 4216.0 27.15 0.31 0.0 Direct Common Stock DENALI THERAPEUTICS INC.

code_A

code  A 		15529.0 136.89 (DNLI)
2023-06-23 2023-06-21 2023-06-21 4 Schenkein David P DIRECTOR acq 4975.0 4.05 0.9 0.0 Direct Common Stock AGIOS PHARMACEUTICALS, INC.

code_M

code  M 		122854.0 55.58 (AGIO)
2023-06-23 2023-06-21 4 Schenkein David P DIRECTOR holding 79082.0 0 14.23 0.0 Amy P Common Stock AGIOS PHARMACEUTICALS, INC.

code_

NA 		55.58 (AGIO)
2023-06-23 2023-06-21 4 Schenkein David P DIRECTOR holding 270772.0 0 48.72 0.0 David P Common Stock AGIOS PHARMACEUTICALS, INC.

code_

NA 		55.58 (AGIO)
2023-09-12 2023-09-08 2023-09-08 4 Schenkein David P DIRECTOR acq 240.0 100.0 0.02 0.0 Direct Common Stock REGENERON PHARMACEUTICALS, INC.

code_A

code  A 		240.0 106.74 (REGN)
2024-01-04 2024-01-02 2024-01-02 4 Schenkein David P DIRECTOR acq 42.0 14.89 0.0 0.0 Direct Common Stock REGENERON PHARMACEUTICALS, INC.

code_A

code  A 		282.0 107.13 (REGN)
2024-02-27 2024-02-23 4 Schenkein David P DIRECTOR holding 270772.0 0 48.18 0.0 David P Common Stock AGIOS PHARMACEUTICALS, INC.

code_

NA 		56.19 (AGIO)
2024-02-27 2024-02-23 4 Schenkein David P DIRECTOR holding 79082.0 0 14.07 0.0 Amy P Common Stock AGIOS PHARMACEUTICALS, INC.

code_

NA 		56.19 (AGIO)
2024-02-27 2024-02-23 2024-02-23 to 2024-02-26 4 Schenkein David P DIRECTOR acq 68142.0 47.56 12.13 31.64 Direct Common Stock AGIOS PHARMACEUTICALS, INC.

code_M

code  M 		143265.0 thumbnail 56.19 (AGIO)
2024-02-27 2024-02-23 2024-02-23 to 2024-02-26 4 Schenkein David P DIRECTOR dsp 68142.0 35.68 12.13 33.09 Direct Common Stock AGIOS PHARMACEUTICALS, INC.

code_S

code  S 		122854.0 thumbnail 56.19 (AGIO)
2024-02-29 2024-02-27 2024-02-27 4 Schenkein David P DIRECTOR acq 69329.0 38.45 12.34 31.64 Direct Common Stock AGIOS PHARMACEUTICALS, INC.

code_M

code  M 		180325.0 thumbnail 56.19 (AGIO)
2024-02-29 2024-02-27 2024-02-27 4 Schenkein David P DIRECTOR dsp 69329.0 36.07 12.34 34.67 Direct Common Stock AGIOS PHARMACEUTICALS, INC.

code_S

code  S 		122854.0 thumbnail 56.19 (AGIO)
2024-02-29 2024-02-27 4 Schenkein David P DIRECTOR holding 270772.0 0 48.18 0.0 David P Common Stock AGIOS PHARMACEUTICALS, INC.

code_

NA 		56.19 (AGIO)
2024-02-29 2024-02-27 4 Schenkein David P DIRECTOR holding 79082.0 0 14.07 0.0 Amy P Common Stock AGIOS PHARMACEUTICALS, INC.

code_

NA 		56.19 (AGIO)

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-06-05 2023-06-01 2023-06-01 4 Schenkein David P DIRECTOR acq 12649.0 100.0 0.92 30.92 Direct Stock Option (Right To Buy) DENALI THERAPEUTICS INC.

code_A

code  A 		12649.0 136.89 (DNLI)
2023-06-15 2023-06-13 2023-06-13 4 Schenkein David P DIRECTOR acq 3388.0 100.0 0.61 0.0 Direct Restricted Stock Units AGIOS PHARMACEUTICALS, INC.

code_A

code  A 		3388.0 55.58 (AGIO)
2023-06-15 2023-06-13 2023-06-13 4 Schenkein David P DIRECTOR acq 18958.0 100.0 3.41 26.56 Direct Stock Options (Right To Buy) AGIOS PHARMACEUTICALS, INC.

code_A

code  A 		18958.0 55.58 (AGIO)
2023-06-16 2023-06-14 2023-06-14 4 Schenkein David P DIRECTOR acq 39062.0 100.0 4.02 14.83 Direct Stock Option (Right To Buy) PRIME MEDICINE, INC.

code_A

code  A 		39062.0 97.23 (PRME)
2023-06-23 2023-06-21 2023-06-21 4 Schenkein David P DIRECTOR dsp 4975.0 100.0 0.9 0.0 Direct Restricted Stock Unit AGIOS PHARMACEUTICALS, INC.

code_M

code  M 		0.0 55.58 (AGIO)
2023-09-12 2023-09-08 2023-09-08 4 Schenkein David P DIRECTOR acq 2739.0 100.0 0.26 833.23 Direct Non Qualified Stock Option (Right To Buy) REGENERON PHARMACEUTICALS, INC.

code_A

code  A 		2739.0 106.74 (REGN)
2024-01-04 2024-01-02 2024-01-02 4 Schenkein David P DIRECTOR acq 508.0 100.0 0.05 888.34 Direct Non Qualified Stock Option (Right To Buy) REGENERON PHARMACEUTICALS, INC.

code_A

code  A 		508.0 107.13 (REGN)
2024-02-27 2024-02-23 2024-02-23 to 2024-02-26 4 Schenkein David P DIRECTOR dsp 68142.0 49.57 12.13 31.64 Direct Stock Option (Right To Buy) AGIOS PHARMACEUTICALS, INC.

code_M

code  M 		69329.0 thumbnail 56.19 (AGIO)
2024-02-29 2024-02-27 2024-02-27 4 Schenkein David P DIRECTOR dsp 69329.0 100.0 12.34 31.64 Direct Stock Option (Right To Buy) AGIOS PHARMACEUTICALS, INC.

code_M

code  M 		0.0 thumbnail 56.19 (AGIO)

a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)